atomoxetine hydrochloride has been researched along with Cholera Infantum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biglan, K; Gerstenhaber, M; Marsh, L; Williams, JR | 1 |
| Goldman, M; Kampman, KM; Lynch, K; Obrien, CP; Tirado, CF | 1 |
2 trial(s) available for atomoxetine hydrochloride and Cholera Infantum
| Article | Year |
|---|---|
Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antiparkinson Agents; Atomoxetine Hydrochloride; Bipolar Disorder; Cognition Disorders; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Nootropic Agents; Parkinson Disease; Pilot Projects; Prefrontal Cortex; Propylamines; Psychological Tests; Psychotropic Drugs; Severity of Illness Index; Treatment Outcome | 2009 |
Atomoxetine for treatment of marijuana dependence: a report on the efficacy and high incidence of gastrointestinal adverse events in a pilot study.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Feasibility Studies; Female; Gastrointestinal Diseases; Humans; Incidence; Male; Marijuana Abuse; Pilot Projects; Propylamines | 2008 |